Hoosier Cancer Research Network on Facebook
Login to Oncore Network
A Randomized Phase II Study of Atezolizumab and Bevacizumab with Y-90 TARE in Patients with Unresectable Hepatocellular Carcinoma (HCC)
Status: Closed to Accrual Read More
Facebook
Hoosier Cancer Research Network on Facebook
Linked In
You Tube
Twitter